Virology tidbits

Monday, 7 November 2016

Neuroteratogenic Viruses: ZIKV, the placenta and IUGR

Following the emergence of Zika Virus (ZIKV) in the Americas in 2015, Brazil became the first country to report an increase in cases of microcephaly, followed by other countries including Colombia and the USA and ZIKV associated cases of foetal and neonatal microcephaly have been reported since elsewhere. ZIKV therefore joins five other neuroteratogenic viruses that cause neurological disorders in humans in addition to other neuroteratogenic viruses which have been associated with abnormal neurodevelopment in animals.

In humans, the most common infectious neuroteratogenic agents are summarised by the mnemonic “TORCH(S)” (Toxoplasmosis, Others, Rubella, (Human) Cytomegalovirus, Herpes Simplex, Syphilis) with ZIKV either classified as “Others” or by expanding the mnemonic to TORCHSZ and indeed health authorities in affected countries regularly test cases of microcephaly suspected to be associated with neurological infections not only for ZIKV but also for the presence of TORCH(S). Microcephaly however is only one outcome of CNS defects that are associated with the infection of foetal neural cells with infectious agents, as illustrated by the wide range of symptoms of neonate that include hydrocephalus, cerebellar dysplasia, hypomyelinogenesis or microphthalmia.

Common to all pathogens is, that they infect the foetus in utero rather than intra partum or vertical by breastfeeding, suggesting that the infection of neural precursor or mature neurons during the development of the foetal brain causes abnormal foetal brain development. Therefore, it is crucial to examine both the ability of neuroteratogenic viruses to infect and replicate in vaginal tissue as well to examine the mechanism of transplacental transmission and thus infection of embryonic and/or foetal cells.

Table: Neuroteratogenic viruses

In the case of ZIKV, the intra vaginal infection of wt, Irf-3 Irf-7 -/-, and Ifnar-1 -/+ pregnant mice with ZIKV FSS13025 is followed by transplacental transmission of ZIKV with the offspring of infected mice displaying signs of intrauterine growth restriction (IUGR). IUGR, signs of microcephaly including extensive apoptosis of cortical progenitor cells have also been demonstrated in the offspring of mice infected i.p. with ZIKV BR, suggesting that ZIKV indeed can cross the placenta. Studies in foetal mice displaying IUGR however frequently display neuronal cells that undergo virus independent apoptosis, i.e. the absence of viral antigen in neuronal cells undergoing apoptosis, suggesting that ZIKV infection can also cause bystander apoptosis and/or tissue injury independent of the initial viral cytopathic effect. Indeed, a recent study suggests that the infection of cranial crest neuronal cells (CNCC) with ZIKV MR766 only induces limited apoptosis of infected CNCC with extensive apoptosis of non-infected cells by inducing the expression of inflammatory cytokines thus inducing T lymphocyte dependent cytolysis as well as apoptosis of neighbouring neuronal cells, which might explain the intracranial calcifications that are commonly seen in cases of ZIKV associated microcephaly.

Transplacental transmission of ZIKV

The placenta constitutes the principal barrier between the viraemic mother and the non-infected embryo/foetus. In both humans and mice, chorionic villi are separated from the maternal blood by layers of placental multinucleate syncytia of trophoblast cells (PTB or STB) and Cytotrophoblasts(CTB), either by one cell layer (hemomonochorial; primate) or multiple cell layers (hemotrichorial; mouse), whereas in pigs the chorionic villi are separated from the maternal blood by the uterine epithelium, endothelium and connective tissue.

In primates, mononuclear extravillious trophoblasts (distally) extent into the decidua and are thus being exposed to maternal fibroblasts and leukocytes. The transmigration of leukocytes however is prevented due to the absence of intercellular junctions of the epithelium. In addition, STB are also expressing high levels of TLR and thus are capable of inducing a strong antiviral response as evidenced by high levels of Interferon-delta type 1 (IFN-𝚫1) infected with ZIKV FSS 13025 or ZIKV MR766 as well as potentially inducing the degradation of endosomes that contain ZIKV particles by autophagy following viral entry. As mentioned above and as discussed in a previous post, ZIKV can infect and replicate in cells of the vaginal mucosa. It is therefore possible that the secretion of inflammatory cytokines can disrupt the placental barrier and thus infect foetal cells. Alternatively, ZIKV –and other neuroteratogenic viruses- may infect foetal M2 macrophages (Hofbauer cells) that express Fcg receptors as well as syncytiotrophoblasts (STB) that express foetal/neonatal Fc receptors (FcRn). This notion is supported by findings that ZIKV PR 2015 infects both Hofbauer cells and STB, concomitant with the expression of IFN-a and CXLB.

To investigate if placental tissue supports the replication of ZIKV and thus can transmit ZIKV to foetal tissue, organotypic cultures of chorionic or chorionic villus explants derived from human placental tissues obtained at different times gestation or Amniotic Epithelial Cells (AmEpC) and other cell lines including Human Placental Fibroblasts (HPF), Trophoblast Progenitor Cells (TBPC), and Chorionic Trophoblasts (CTB) obtained from foetal membranes were infected with different ZIKV strains, namely ZIKV Nica 1-16 (Nicaragua), ZIKV Nica 2-16 (Nicaragua), ZIKV MR766 (Uganda), ZIKV SBH2015 (Brazil), ZIKV PRVABC59 (Puerto Rico) or ZIKV FSS13025 (Cambodia) with viral replication being detected by immunofluorescence analysis for the viral E glycoprotein and the viral nonstructural NS3 protein as well as determining viral titres by plaque and focus forming assays.

AmEpC derived from mid- and late- gestation as well as CTB, TBPC, HPF or Human Umbilical Cord Vein Endothelial Cells (HUVEC) infected with either ZIKV MR766 or ZIKV Nica 1-16 stained positive both for NS3 and E protein at 72 hrs p.i. indicating that both ZIKV MR766 and ZIV Nica 1-16 replicate in cells derived from the human placenta. Furthermore, viral replication was accompanied by the release of viral particles, although the highest titres were obtained from AmEpC derived from the human placenta mid gestation infected with ZIKV MR766, ZIKV Nica 1-16 or ZIKV Nica 2-16 strains when compared to HPF, CTB, TBPC or HUVEC, which confirms previous reports that ZIKV PR 2015 can infect CTB derived from full term (> 37 weeks) human placentas.

Similar to CTB or TBCP, ZIKV MR766 and ZIKV FSS13025 can infect and replicate in Placental Trophoblast Cell lines such as JEG-3 and HTR-8 although these ZIKV strains do not replicate in Primary Human Trophoblast Cells (PHT) isolated from full term placental tissue, indicating that the ability to infect placental tissue with ZIKV varies during different stages of the pregnancy as well as between cell types. Indeed, the expression levels of the main ZIKV receptor Axl and a co-receptor, TIM-1, in AmEpC isolated from mid- to late gestation is strong with Axl being located at the plasma membrane during mid-gestation and vesicular during the late stages of gestation, indicating that viral entry might be inhibited during the later stages of gestation. In TBPC, TIM-1 -a potential ZIKV co-receptor- is expressed both at 7.3 and 15.6 weeks gestational stage, whereas the expression of Axl is increased at week 15.6. Primary CTB however do not express Axl at late stages of gestation (in contrast to mid stage gestation), suggesting that at this point ZIKV entry might be primarily mediated by TIM-1.

Interestingly, ZIKV MR766 infected CTB cease to proliferate as measured by Ki-67 staining, suggesting that the infection of CTB with ZIKV MR766 induces a cell cycle arrest, which might be accompanied by the induction of apoptosis or senescence. In contrast to CTB, syncytiotrophoblasts (STB) do not support viral replication although the viral E protein can be detected in cytoplasmic vesicles in ZIKV Nica 1-16 infected indicating that viral replication might be inhibited either post-entry by preventing the release of the viral genome or by degradation of de novo synthesized viral proteins probably due to high levels of IFN-l1 as discussed above and in a previous post as well as the other factors such as IFITM-3.

In addition to AmEpC, CTB and STB, ZIKV has also been shown to infect primary decidual fibroblasts (dFibroblasts) as demonstrated by high viral titres of and the presence of ZIKV E protein in dFibroblasts infected with a ZIKV strain derived from a French patient that got infected in Brazil (ZIKV FR) 72 hrs p.i..In addition to dFibroblasts, decidual Macrophages are also susceptible to ZIKV FR, supporting observations that ZIKV PR 2015 can infect and replicate in placental macrophages (Hofbauer cells).

In conclusion, ZIKV MR766 and ZIKV Nica1/2-2016 isolates have been demonstrated to productively infect Amniotic Cell Epithelial Cells (AmEpC), Trophoblast Progenitor Cells (TBPC), Chorionic Trophoblasts (CTB), human placental/decidual Fibroblast cells (HPF/dFibroblasts), decidual Macrophages and Hofbauer cells particularly if these cells were obtained from placental tissue early or mid-stage gestation and thus allow the infection of foetal neuronal progenitor cells or foetal macrophages. Decidual macrophages play a key role in regulating the vascular remodelling during pregnancy and secrete a wide range of cytokines including Interleukin-1β, -2, -4, -5, -6, -8, -10, -13 and TNF-α as well as proteases (matrix metalloproteinase-1, -2, -7, -9, and -10). The infection of dMacrophages therefore might induce inflammation and tissue damage following ZIKV infection as well as abnormal vascular development of the human placenta, thus be at least a contributing factor in the development of IUGR and potentially in ZIKV associated miscarriages independent of abnormal neural development.

Moreover, the infection of Fcg receptor (Fcg R) bearing foetal STB or CTB as well as maternal cells of the basal and parietal decidua including Hofbauer cells might be enhanced by transcytosis of IgG-ZIKV complexes consisting of DENV cross reactive antibodies and/or maternal ZIKV antibodies and ZIKV particles. In this instance, the IgG-ZIKV complex enters the cell via phagocytosis of the complex after the activation of the FcgR which induces the phosphorylation of the immunoreceptor tyrosine based activation motif (ITAM), thus allowing the recruitment of Zap70 and Syk family proteins and activation of downstream pathways (including MAPK, PI3-K,PLCg, Rho, and Rac). These downstream pathways in turn contribute to vascular injury due to a “cytokine storm”, the release of high levels of pro-inflammatory cytokines, thus potentially contributing to the development of IUGR rather than abnormal brain development. Further experimental data are however needed to confirm this hypothesis.

The uptake of ZIKV into macrophages might also be stimulated by autophagy similar to antibody enhanced uptake of DENV into human pre-basophil/Mast cells.In this case, sub-neutralising antibodies from a prior infection stimulate the uptake of IgG-DENV complexes in both KU812 and HMC-1 cells which can be inhibited by either 3-MA or the expression of a catalytically inactive mutant of Atg4B, Atg4B^C74A. It should be noted however that it has not be conclusively proven that autophagy is required for viral uptake; based on the published results, it cannot be ruled out that the IgG-DENV complex increases viral entry via an autophagy independent mechanism and that the inhibition of viral replication by 3-MA or Atg4B^C74Aoccurs by inhibiting the formation of viral replication centres. and/or by inhibiting the antiviral interferon type I signalling pathway.

Tuesday, 18 October 2016

Autophagy in CSFV and ZIKV infected cells: persistence versus neurodegenerative disease

Zika Virus (ZIKV) was first isolated in 1947 from a sentinel monkey in Uganda and associated with human infection in 1954 when neutralizing antibodies were detected in the sera of residents in India, with antibodies also being found in residents from various African countries. ZIKV is mosquitoe-borne Flavivirus that is predominantly transmitted via Aedes Agypti, although sexual transmission (female to male, male to female, male to male) and transmission via blood transfusion has also been reported.

Clinically most cases are asymptomatic and symptomatic cases only present themselves with relative benign symptoms in adults, the exception being Guillain Barre Syndrome. During in the current outbreak in the Americas and –albeit only retroactively identified- in the 2013/2014 outbreak in French Polynesia, ZIKV has been identified to a causative agent of abnormal foetal brain development, leading to congenital defects, namely microcephaly, anomalies of the CNS, miscarriages and in rare cases foetal and/or neonatal death. Studies in both wt and immunodeficient mice confirmed that the infection of pregnant mice with various strains of ZIKV including strains from Asia (SZ01, FSS1305), Oceania (H/PF/2013), Brazil (Paraiba 2015), Puerto Rico (PRVABC59) and Mexico (MEX_1_7) indeed can cause abnormal development of the (foetal) brain by apoptosis of neural progenitor cells similar to representatives of the African strain, ZIKV MR766 (Uganda, 1947) and ZIKV IbH30656 (Nigeria, 1968), tested. In addition, the infection of brain organoids, neurospheres, human (foetal) Neural Progenitor Cells (h (f) NPC) and human Neural Stem Cells (NSC) with various ZIKV strains including a primary isolate from Africa, ZIKV ArB41644, demonstrated that ZIKV can indeed induce apoptosis of proliferating but probably not of mature neurons. Recently the infection of cranial neural crest cells (CNCC) with either ZIKV MR766 or ZIKV H/PF/2013 has been reported to induce high levels of cytokines that are detrimental for neurogenesis, causing bystander apoptosis of uninfected neuronal cells. Infected CNCC do not undergo apoptosis at 24 hrs p.i. but apoptosis is increased at 72 hrs p.i. confirming that both ZIKV MR766 and ZIKV H/PF/2013 can induce apoptosis of CNCC although only approx. 8% of ZIKV infected CNCC undergo apoptosis compared to 4% of mock or DENV infected CNCC, indicating that CNCC support viral infection whilst being protected against apoptosis probably by VEGF as indicated by increased secretion of VEGF which has been shown to inhibit apoptosis of human microvascular endothelial cells (HUMEC).

In brains of wt C57BL/6 mice intracranial infected with ZIKV MR766 day 7 postnatal and analysed day 4 p.i. brain mass is reduced compared to mock infected mice by 25%, as well as showing an increase of NeuN⁺and CTIP⁺ cells that also positive for active Caspase-3, indicating that ZIKV MR766 does not or rarely induces apoptosis in corticospinal cells, neuronal progenitor cells and astrocytes but in mature neurons in postnatal mice. These results are in contrast with previously discussed results that indicate that in foetal mice, mature neurons are ZIKV negative and do not undergo apoptosis upon ZIKV infection. In contrast to mice infected at day 7 postnatal, mice infected at three weeks postnatal do show less severe apoptosis as measured by the presence of active Caspase-3 although similar to day 7 postnatal infected mice, widespread apoptosis of NeuN⁺cells is detected by the presence active Caspase-3. When interpreting these experiments however, one has to bear in mind that ZIKV MR766 is a neurotrophic strain adapted to mice brain due to repeated intracranial passage.

Autophagy and viral infection

Autophagy is a cellular degradation pathway that involves the sequestration of cytoplasmic component such as organelles, protein aggregates or pathogens with (transient) double membrane most commonly derived from the ER, forming a phagosome that ultimately matures into the autophagosome and is degraded by lysosomal enzymes such as acidic hydrolases upon fusion with the lysosome. In general, basal autophagy is part of the turnover of RNA, proteins and organelles but can be induced in cells undergoing various forms of stress, including starvation. Both genome wide screens and large scale proteomic basic screens identified a substantial number of autophagy related regulators, including but not limited to autophagy related genes (ATG) that initiate the formation and the maturation of autophagosomes, aided by improved imaging, as well as degrading substrates such as RNA in lysosomes.

In the case of viral infections, the interactions between positive sense RNA viruses is of particular interest since autophagosomes might contribute to the decay of (viral) RNA in lysosomes by RNase T2, RNASE1 and RNASE6/RNase K6. Although it has not been determined experimentally, viral RNA might be targeted to lysosomes directly (similar to LINE 1 via processing bodies/stress granules that interact with NDP52/CALCOCO2 or p62/SQSTM-1) or as part of a complex with viral and/or cellular proteins that form a RNA-Protein Binding complex (RBP).

Figure: General outline of the autophagy pathway

More importantly however, RNA viruses such as Chikungunya Virus (CHIKV), Coronaviruses’ (CoV), Polio Virus, Measles Virus, DENV, Hepatitis C Virus (HCV) or Classical Swine Fever Virus (CSFV) can utilize autophagosomes and/or double membrane vesicles (DMV) to increase viral replication. As discussed in previous posts, in the case of CHIKV or CoV, the formation of viral replication centers (RC) is dependent on the autophagy machinery, including ATG5 and Beclin-1, whilst in others –such as HCV- autophagy is also required for exit of the mature virions as exosomes. To prevent degradation of assembled viral particles, viral proteins that inhibit the fusion of the autophagosome with the lysosome by binding Beclin-1 for instance are expressed late in the replication cycle.

Figure: Regulation of the autophagy pathway by CoV proteins as an example for the regulation of
autophagy by viral proteins

Autophagy itself can be activated via the inhibition of the Phosphatidylinositol-3 Kinase (PI3-K)-Akt-mTOR pathway, thereby inducing the phosphorylation of the ULK-1 complex and subsequently inducing the formation of the phagosome and autophagosome. This pathway is activated by the binding of growth factors such as Insulin to their respective cell surface receptor followed by the conversion of membrane bound Phosphatidylinositol-4’,5’-bisphosphate (PIP₂) to Phosphatidylinositol-3’,4’,5’-trisphosphate (PIP₃) thus recruiting Akt to the plasma membrane and phosphorylating Akt. Phosphorylated Akt activates the TSC1/2 complex, the GTPase activating protein (GAP) of Rheb. Activated Rheb binds and activates the mTOR-Raptor complex, inhibiting the formation of autophagosomes and thus autophagy.

Indeed, preventing the phosphorylation of Akt both at Thr 308 and Ser473 reduces the phosphorylation of mTOR at Ser2448 thus promoting autophagy whereas the ectopic expression of a constitutively active myristoylated mutant of Akt (Akt3 E17K) inhibits autophagy.

Figure: Akt inhibits the formation of autophagosomes via mTORC-1

The inhibition of autophagy in neuronal cells can induce neurodegeneration and autophagy defects –including lysosomal defects- have been implicated in Huntington Disease and ALS as well as in microcephaly and megalencephaly-polydactyly-polymicrogyria-hydrocephalus.

CSFV and Autophagy: where autophagy meets viral persistence

Before discussing recent results concerning ZIKV and autophagy, it is worth examining the role of autophagy in cells persistently infected with CSFV and how autophagy contributes to the survival of viral infected cells.

Classical Swine Fever Virus (CSFV) is positive strand RNA virus which is classified as a Pestivirus within the Flaviviridae, causing highly virulent disease in swine characterized by a high fever, leukopenia and hemorrhages with a mortality. In infected PK-15 and 3D4/2 cells, CSFV inhibits the type I Interferon response, leading to persistent infection in the absence of apoptosis. In a recently published study, CSFV has been shown to induce the formation of LC3-II positive (mature) autophagosomes as early as 48 hrs p.i. and both the viral E2 and NS5A proteins have been shown to localise in LC3 positive vesicles as early as 24 hrs p.i. which can be inhibited by 3-Methyladenine (3-MA) as well as by downregulating the expression of either Beclin-1 or LC3-B suggesting that CSFV does induce the formation of autophagosomes as well as autophagic flux as evidenced by decreased levels of p62/SQSTM-1 in CSFV infected PK-5 and 3D4/2 cells.

Autophagy induction by CSFV however not only increases viral replication –presumably by forming viral RC- but also decreases viral induced apoptosis and decreasing mRNA levels of genes related to the type I Interferon response and IFN stimulated genes (ISG).

CSFV induces apoptosis via activation of the intrinsic apoptotic pathway, i.e. via activation of Caspase-9 and Caspase-3, by inducing the accumulation of mitochondrial reactive oxygen species (ROS) if autophagy is inhibited in infected PK-5 and 3D4/2 cells by shBeclin1 or shLC3 which can be inhibited by either Z-VAD (a pan caspase inhibitor) or Necrostatin-1 (Nec-1/ROS scavenger). In addition to the intrinsic pathway, the extrinsic –Caspase-8 dependent- is also triggered in CSFV infected autophagy deficient cells.

CSFV induction of mitochondrial ROS not only induces the activation of apoptosis but also induces autophagy and thus promotes the clearance of damaged mitochondria via mitophagy, which is indirectly indicated by the increase of copy numbers of mitochondrial DNA in autophagy deficient PK-5 and 3D4/2 CSFV infected cells (flow cytometry using JC-1, NAO or TMRE was not performed) and/or promotes autophagy in a Nrf-2 dependent manner.

The accumulation of ROS in CFSV infected cells also induces antiviral signalling via RIG-1 and MDA-5, including increased expression of TNF/TNF-α, IFN-β/IFNB1 and FAS/TNFRSF6 in autophagy deficient CSFV infected cells, thus inducing the extrinsic pathway in an autocrine manner, which is inhibited in shDDX58, shIFIH1 and shMAVS CSFV infected autophagy deficient cells. The induction of autophagy by CSFV therefore might not only promote the clearance of damaged mitochondria but also the decreasing transcripts of ISG via RNautophagy. Similar to other positive strand RNA viruses, CSFV might also induce autophagy via the ER stress response induced by the viral NS2 and NS5A proteins which might play a role in establishing a persistent infection. In addition, the induction of NFκ-B by oxidative stress can also autophagy. If any of those pathways however contributes to viral persistence has not been investigated yet.

Figure: CSFV inhibitors apoptosis and induces autophagy via multiple pathways

Also, so far it has not been demonstrated if CSFV induced formation of ROS also induces the induction of TLR-9 by mitochondrial DNA. In this scenario, a complex of mtDNA and TLR-9 might be degraded via autophagy and thus abrogate antiviral signalling.

ZIKV and autophagy: impairment of autophagic flux linked to ZIKV induced apoptosis ?

In the case of ZIKV, the formation of autophagosome like vesicles has been observed in ZIKV MR766 infected human primary fibroblasts and keratinocytes and in the cytoplasm of C6/36 cells infected with a ZIKV isolate from a patient in Brazil although in A549 cells infected with ZIKV H/PF/2013 no LC3 positive structures have been detected.

Following the infection human foetal neural stem cells (fNSC) infected with either ZIKV MR766, ZIKV H/PF/2013 or ZIKV IbH30656 the formation of neurospheres is significantly impaired at day 7 p.i., as indicated by fewer neurospheres present which are also smaller in size, due to the induction of apoptosis as measured by TUNEL staining. Ina accordance with previously published results, ZIKV infected fNSC derived neurospheres also exhibit a reduction of cell proliferation measured by both BrdU incorporation, suggesting that ZIKV indeed does affect the proliferation of foetal neuronal precursor cells.

Similar to ZIKV MR766 infected human keratinocytes, the infection of fNSC with ZIKV MR766 or ZIKV IbH30656 induces the formation of LC3-II positive autophagosomes, without affecting autophagic flux, indicating that ZIKV infection of fNSC induces the formation of autophagosomes without affecting the formation of autolysosomes as measured by the degradation of p62/SQSTM-1. It should be noted that the infection of HeLa cells transiently transfected with a GFP/RFP-LC3 tandem plasmid with ZIKV MR766 increases GFP+/RFP+ punctae, indicating that the formation of the autolysosome might be inhibited. The discrepancy can either be due to the use of HeLa cells or it might be possible that ZIKV infection leads to the proteasomal degradation of p62/SQSTM-1 in fNSC similar to DENV-2 infected Huh-7 cells.

In any case, treatment of ZIKV infected fNSC with Chloroquine decreases viral RNA/viral titres whilst Rapamycin treatment increases levels of both viral RNA and titers as early as 10 hrs p.i. suggesting that autophagic flux is necessary for viral replication. Based on the results described for CSFV above, autophagic flux might be necessary to prevent viral induced apoptosis and/or antiviral signalling; therefore, treatment with Chloroquine might prevent the degradation of viral RNA-TLR complexes and thus induce antiviral signalling whereas in untreated cells residual autophagy might be sufficient for inducing a partial antiviral response. Treatment of fNSC with 3-MA inhibits viral replication, suggesting that autophagosome formation is required for viral replication, probably for the formation of viral RC.

The ability to initiate the formation of the autophagosome is further highlighted by results that the replication of ZIKV MR766 in Atg3 -/- MEF and Atg5 -/-/MEF as well as in MEF transfected with siATG13 or siATG3 is lower when compared to wt MEF.

In DENV and HCV infected cells, the localisation of viral proteins induces the formation of viral replication complexes by utilizing the autophagy machinery; in a similar way, CoV nsp-3 and -4 have been shown to induce the formation of LC3-II positive vesicles that are derived from the ER.

In the case of ZIKV, the expression of NS4A and NS4B induces the formation of GFP-LC3 positive punctae in HeLa-GFP-LC3 cells which is more pronounced if both NS4A and NS4B are co-expressed. Similar to ZIKV MR766 infected cells, the co-expression of NS4A and NS4B increases the percentage of GFP+/RFP+ positive punctae, indicating that autophagic flux might be inhibited, although p62/SQSTM-1 levels are decreased which is probably due to proteasomal degradation of p62/SQSTM-1 (as described above).

Based on immunofluorescence data and on data obtained from DENV NS4A and DENV NS4B, both ZIKV NS4A and NS4B are localised at the ER, suggesting that autophagy might be induced by the ER stress response.

Figure: Topology of DENV NS4A and NS4B

As described before, the ER stress response can initiate autophagy by negatively regulating the PI-3-K/Akt pathway. Indeed, ZIKV NS4A and NS4B reduce the phosphorylation of Akt at both Thr308 and Ser473 as well as of mTOR at Ser2448 which can be reversed by the expression of a constitutively active form of Akt, Myr-HA-Akt3 E17K, in ZIKV MR766 infected fNSC or HeLa cells, suggesting that NS4A and NS4B induce the ER stress response, although it has not proven experimentally yet.

Figure:ZIKV NS4A and NS4B inhibits PI3-K and therefore activates the formation of autophagosomes

In addition, the expression of ZIKV NS4A and NS4B decreases the proliferation of fNSC as measured by Ki67, which is more pronounced if both NS4A and NS4B are co-expressed. Since prolonged ER stress induces not only autophagy but also apoptosis, the (co-) expression of NS4A and NS4B might induce both autophagy and apoptosis although the percentage of apoptotic cells following the transfection of fNSC with ZIKV NS4A/B has not been determined.

Figure: ZIKV NS4A and NS4B decrease the expression of Ki-67 and the proliferation of fNSC

In conclusion, the infection of fNSC with ZIKV MR766, ZIKV IbH30656 and ZIKV H/PF/2013 induces apoptosis, decreased cell proliferation, smaller neurospheres and the formation of autophagosomes with impaired autophagic flux, the latter probably induced by both NS4A and NS4B protein. The notion that ZIKV MR766 inhibits the fusion of the autophagosome with the lysosome -or lysosomal maturation- and thus induces neurodegeneration by impairing the degradation of autophagic substrates is supported by findings in ZIKV MR766 infected hNPC, the expression of LAMP-2 is downregulated.

Figure: ZIKV and autophagy

If the impairment of autophagic flux however is linked to the induction of apoptosis in ZIKV infected primary neuronal cells has not been demonstrated. It might be possible that similar to CSFV infected cells, autophagy is required for abrogating antiviral signalling.
It should be noted that the infection of hNPC with ZIKV MR766 downregulates the expression of key proteins involved in the onset and progression of stress induced autophagy. Therefore, ZIKV infection of neuronal and non-neuronal cells might inhibit stress induced and selective autophagy whilst promoting the formation of viral RC. It is therefore important to analyse if the formation of viral RC is totally or only partially dependent on the ability to induce the formation of autophagosomes since viral proteins might be able to induce some of the processes required for the formation of RC independent of the autophagy machinery.

Table: Genes that are up- or downregulated in ZIKV MR766 infected hNPC

A screen of FDA approved revealed that both Bortezomib and Ivermectin inhibit the replication of ZIKV Mex_1_7 in infected Huh-7, HeLa and/or Human Amnion Epithelial Cells. Both Bortezomib and Ivermectin induce apoptosis of cancer cells by inhibiting autophagy, indicating that in ZIKV infected (neuronal) cells autophagy might not only support viral replication by forming viral RC but also by inhibiting apoptosis at least in the early stages of viral replication. If the induction of autophagy has also consequences for the establishment of persistently infected cells, however remains to be seen.

Further reading

Pei J, Zhao M, Ye Z, Gou H, Wang J, Yi L, Dong X, Liu W, Luo Y, Liao M, & Chen J (2014). Autophagy enhances the replication of classical swine fever virus in vitro. Autophagy, 10 (1), 93-110 PMID: 24262968

Pei J, Deng J, Ye Z, Wang J, Gou H, Liu W, Zhao M, Liao M, Yi L, & Chen J (2016). Absence of autophagy promotes apoptosis by modulating the ROS-dependent RLR signaling pathway in classical swine fever virus-infected cells. Autophagy, 12 (10), 1738-1758 PMID: 27463126

Summerfield A, Knötig SM, & McCullough KC (1998). Lymphocyte apoptosis during classical swine fever: implication of activation-induced cell death. Journal of virology, 72 (3), 1853-61 PMID: 9499036

Frankel LB, Lubas M, & Lund AH (2016). Emerging connections between RNA and autophagy. Autophagy, 1-21 PMID: 27715443

He L, Zhang YM, Lin Z, Li WW, Wang J, & Li HL (2012). Classical swine fever virus NS5A protein localizes to endoplasmic reticulum and induces oxidative stress in vascular endothelial cells. Virus genes, 45 (2), 274-82 PMID: 22718084

He L, Zhang Y, Fang Y, Liang W, Lin J, & Cheng M (2014). Classical swine fever virus induces oxidative stress in swine umbilical vein endothelial cells. BMC veterinary research, 10 PMID: 25439655

Zhang F, Hammack C, Ogden SC, Cheng Y, Lee EM, Wen Z, Qian X, Nguyen HN, Li Y, Yao B, Xu M, Xu T, Chen L, Wang Z, Feng H, Huang WK, Yoon KJ, Shan C, Huang L, Qin Z, Christian KM, Shi PY, Xu M, Xia M, Zheng W, Wu H, Song H, Tang H, Ming GL, & Jin P (2016). Molecular signatures associated with ZIKV exposure in human cortical neural progenitors. Nucleic acids research, 44 (18), 8610-8620 PMID: 27580721

Calvet, G., Aguiar, R., Melo, A., Sampaio, S., de Filippis, I., Fabri, A., Araujo, E., de Sequeira, P., de Mendonça, M., de Oliveira, L., Tschoeke, D., Schrago, C., Thompson, F., Brasil, P., dos Santos, F., Nogueira, R., Tanuri, A., & de Filippis, A. (2016). Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study The Lancet Infectious Diseases, 16 (6), 653-660 DOI: 10.1016/S1473-3099(16)00095-5

Cauchemez S, Besnard M, Bompard P, Dub T, Guillemette-Artur P, Eyrolle-Guignot D, Salje H, Van Kerkhove MD, Abadie V, Garel C, Fontanet A, & Mallet HP (2016). Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study. Lancet (London, England), 387 (10033), 2125-32 PMID: 26993883

Cloëtta D, Thomanetz V, Baranek C, Lustenberger RM, Lin S, Oliveri F, Atanasoski S, & Rüegg MA (2013). Inactivation of mTORC1 in the developing brain causes microcephaly and affects gliogenesis. The Journal of neuroscience : the official journal of the Society for Neuroscience, 33 (18), 7799-810 PMID: 23637172

Cugola FR, Fernandes IR, Russo FB, Freitas BC, Dias JL, Guimarães KP, Benazzato C, Almeida N, Pignatari GC, Romero S, Polonio CM, Cunha I, Freitas CL, Brandão WN, Rossato C, Andrade DG, Faria Dde P, Garcez AT, Buchpigel CA, Braconi CT, Mendes E, Sall AA, Zanotto PM, Peron JP, Muotri AR, & Beltrão-Braga PC (2016). The Brazilian Zika virus strain causes birth defects in experimental models. Nature, 534 (7606), 267-71 PMID: 27279226

De Carvalho NS, De Carvalho BF, Fugaça CA, Dóris B, & Biscaia ES (2016). Zika virus infection during pregnancy and microcephaly occurrence: a review of literature and Brazilian data. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 20 (3), 282-9 PMID: 27102780

Arroba AI, Rodríguez-de la Rosa L, Murillo-Cuesta S, Vaquero-Villanueva L, Hurlé JM, Varela-Nieto I, & Valverde ÁM (2016). Autophagy resolves early retinal inflammation in Igf1-deficient mice. Disease models & mechanisms, 9 (9), 965-74 PMID: 27483352

Paul P, & Münz C (2016). Autophagy and Mammalian Viruses: Roles in Immune Response, Viral Replication, and Beyond. Advances in virus research, 95, 149-95 PMID: 27112282

McLean JE, Wudzinska A, Datan E, Quaglino D, & Zakeri Z (2011). Flavivirus NS4A-induced autophagy protects cells against death and enhances virus replication. The Journal of biological chemistry, 286 (25), 22147-59 PMID: 21511946

Liang Q, Luo Z, Zeng J, Chen W, Foo SS, Lee SA, Ge J, Wang S, Goldman SA, Zlokovic BV, Zhao Z, & Jung JU (2016). Zika Virus NS4A and NS4B Proteins Deregulate Akt-mTOR Signaling in Human Fetal Neural Stem Cells to Inhibit Neurogenesis and Induce Autophagy. Cell stem cell PMID: 27524440

Barrows NJ, Campos RK, Powell ST, Prasanth KR, Schott-Lerner G, Soto-Acosta R, Galarza-Muñoz G, McGrath EL, Urrabaz-Garza R, Gao J, Wu P, Menon R, Saade G, Fernandez-Salas I, Rossi SL, Vasilakis N, Routh A, Bradrick SS, & Garcia-Blanco MA (2016). A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection. Cell host & microbe, 20 (2), 259-70 PMID: 27476412

Tang, H., Hammack, C., Ogden, S., Wen, Z., Qian, X., Li, Y., Yao, B., Shin, J., Zhang, F., Lee, E., Christian, K., Didier, R., Jin, P., Song, H., & Ming, G. (2016). Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth Cell Stem Cell, 18 (5), 587-590 DOI: 10.1016/j.stem.2016.02.016

Goodfellow FT, Tesla B, Simchick G, Zhao Q, Hodge T, Brindley MA, & Stice SL (2016). Zika Virus Induced Mortality and Microcephaly in Chicken Embryos. Stem cells and development PMID: 27627457

Sir D, Kuo CF, Tian Y, Liu HM, Huang EJ, Jung JU, Machida K, & Ou JH (2012). Replication of hepatitis C virus RNA on autophagosomal membranes. The Journal of biological chemistry, 287 (22), 18036-43 PMID: 22496373

Adams Waldorf, K., Stencel-Baerenwald, J., Kapur, R., Studholme, C., Boldenow, E., Vornhagen, J., Baldessari, A., Dighe, M., Thiel, J., Merillat, S., Armistead, B., Tisoncik-Go, J., Green, R., Davis, M., Dewey, E., Fairgrieve, M., Gatenby, J., Richards, T., Garden, G., Diamond, M., Juul, S., Grant, R., Kuller, L., Shaw, D., Ogle, J., Gough, G., Lee, W., English, C., Hevner, R., Dobyns, W., Gale, M., & Rajagopal, L. (2016). Fetal brain lesions after subcutaneous inoculation of Zika virus in a pregnant nonhuman primate Nature Medicine DOI: 10.1038/nm.4193

Metz P, Chiramel A, Chatel-Chaix L, Alvisi G, Bankhead P, Mora-Rodriguez R, Long G, Hamacher-Brady A, Brady NR, & Bartenschlager R (2015). Dengue Virus Inhibition of Autophagic Flux and Dependency of Viral Replication on Proteasomal Degradation of the Autophagy Receptor p62. Journal of virology, 89 (15), 8026-41 PMID: 26018155

Huang J, Li Y, Qi Y, Zhang Y, Zhang L, Wang Z, Zhang X, & Gui L (2014). Coordinated regulation of autophagy and apoptosis determines endothelial cell fate during Dengue virus type 2 infection. Molecular and cellular biochemistry, 397 (1-2), 157-65 PMID: 25138703

Ho HK, White CC, Fernandez C, Fausto N, Kavanagh TJ, Nelson SD, & Bruschi SA (2005). Nrf2 activation involves an oxidative-stress independent pathway in tetrafluoroethylcysteine-induced cytotoxicity. Toxicological sciences : an official journal of the Society of Toxicology, 86 (2), 354-64 PMID: 15901913

Ravikumar, B., Sarkar, S., Davies, J., Futter, M., Garcia-Arencibia, M., Green-Thompson, Z., Jimenez-Sanchez, M., Korolchuk, V., Lichtenberg, M., Luo, S., Massey, D., Menzies, F., Moreau, K., Narayanan, U., Renna, M., Siddiqi, F., Underwood, B., Winslow, A., & Rubinsztein, D. (2010). Regulation of Mammalian Autophagy in Physiology and Pathophysiology Physiological Reviews, 90 (4), 1383-1435 DOI: 10.1152/physrev.00030.2009

Menzies FM, Fleming A, & Rubinsztein DC (2015). Compromised autophagy and neurodegenerative diseases. Nature reviews. Neuroscience, 16 (6), 345-57 PMID: 25991442

Li, Y., Chen, B., Zou, W., Wang, X., Wu, Y., Zhao, D., Sun, Y., Liu, Y., Chen, L., Miao, L., Yang, C., & Wang, X. (2016). The lysosomal membrane protein SCAV-3 maintains lysosome integrity and adult longevity The Journal of Cell Biology DOI: 10.1083/jcb.201602090

De Leo MG, Staiano L, Vicinanza M, Luciani A, Carissimo A, Mutarelli M, Di Campli A, Polishchuk E, Di Tullio G, Morra V, Levtchenko E, Oltrabella F, Starborg T, Santoro M, di Bernardo D, Devuyst O, Lowe M, Medina DL, Ballabio A, & De Matteis MA (2016). Autophagosome-lysosome fusion triggers a lysosomal response mediated by TLR9 and controlled by OCRL. Nature cell biology, 18 (8), 839-50 PMID: 27398910

Draganov D, Gopalakrishna-Pillai S, Chen YR, Zuckerman N, Moeller S, Wang C, Ann D, & Lee PP (2015). Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death. Scientific reports, 5 PMID: 26552848

Selimovic D, Porzig BB, El-Khattouti A, Badura HE, Ahmad M, Ghanjati F, Santourlidis S, Haikel Y, & Hassan M (2015). Corrigendum to "Bortezomib/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cells". [Cell Signal. 25(1)Jan 2013 308-18]. Cellular signalling PMID: 25666930